nasdaq-mynz-mainzbiomed.png
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
03 juin 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Results of 2024 Annual General Meeting
31 mai 2024 17h01 HE | Mainz BioMed NV
Mainz Biomed Reports Results of 2024 Annual General Meeting
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
28 mai 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
20 mai 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
07 mai 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Full Year 2023 Financial Results
09 avr. 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Reports Full Year 2023 Financial Results
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
19 mars 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
nasdaq-mynz-mainzbiomed.png
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
18 mars 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
12 mars 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations